Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G C Jayson

Showing results (1-10 of 66) with videos related to

Pageof 7
Sort By:
British Journal of Cancer|February 22, 2002
Weekly platinum chemotherapy for recurrent ovarian cancerA Clamp, G C Jayson
Anti-Cancer Drugs|August 21, 2002
The clinical development of the bryostatinsA Clamp, G C Jayson
Expert Opinion on Biological Therapy|December 1, 2001
VEGF antagonistsJ Hasan, G C Jayson
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 1996
Carcinomatous meningitis in solid tumoursG C Jayson, A Howell
British Journal of Cancer|June 12, 2003
Oral melphalan as a treatment for platinum-resistant ovarian cancerJ Hasan, G C Jayson
British Journal of Cancer|January 1, 1997
Heparin oligosaccharides: inhibitors of the biological activity of bFGF on Caco-2 cellsG C Jayson, J T Gallagher
Clinical Oncology (Royal College of Radiologists (Great Britain))|April 24, 2003
The current and future management of malignant ascitesE M Smith, G C Jayson
Current Pharmaceutical Design|February 3, 2004
Resistance to anti-VEGF agentsN C Ton, G C Jayson
British Journal of Cancer|October 20, 2005
The clinical potential of antiangiogenic fragments of extracellular matrix proteinsA R Clamp, G C Jayson
British Journal of Cancer|June 27, 2002
Intra-tumoural microvessel density in human solid tumoursJ Hasan, R Byers, G C Jayson
Pageof 7

Showing results (1-10 of 66) with videos related to

Sort By:
Pageof 7
British Journal of Cancer|February 22, 2002
Weekly platinum chemotherapy for recurrent ovarian cancerA Clamp, G C Jayson
Anti-Cancer Drugs|August 21, 2002
The clinical development of the bryostatinsA Clamp, G C Jayson
Expert Opinion on Biological Therapy|December 1, 2001
VEGF antagonistsJ Hasan, G C Jayson
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 1996
Carcinomatous meningitis in solid tumoursG C Jayson, A Howell
British Journal of Cancer|June 12, 2003
Oral melphalan as a treatment for platinum-resistant ovarian cancerJ Hasan, G C Jayson
British Journal of Cancer|January 1, 1997
Heparin oligosaccharides: inhibitors of the biological activity of bFGF on Caco-2 cellsG C Jayson, J T Gallagher
Clinical Oncology (Royal College of Radiologists (Great Britain))|April 24, 2003
The current and future management of malignant ascitesE M Smith, G C Jayson
Current Pharmaceutical Design|February 3, 2004
Resistance to anti-VEGF agentsN C Ton, G C Jayson
British Journal of Cancer|October 20, 2005
The clinical potential of antiangiogenic fragments of extracellular matrix proteinsA R Clamp, G C Jayson
British Journal of Cancer|June 27, 2002
Intra-tumoural microvessel density in human solid tumoursJ Hasan, R Byers, G C Jayson
Pageof 7